AzTrials
AzTrials

Quality of Life (QOL)NCT06979778

Testing the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia

A study testing See Yourself Differently (syd) mobile app in people with Quality of Life (QOL) and Anxiety, run by iamYiam Limited at 1 site in Saudi Arabia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if using the "See Yourself Differently" (syd) app can help improve quality of life and mental health for university students in Saudi Arabia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Quality of Life (QOL), Anxiety, Stress
What is being tested?
See Yourself Differently (syd) mobile app
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteSaudi Arabia
Study dates
May 2025to Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years.
  • Enrolled as a full-time medical student at the Alfaisal university.
  • Owning a smartphone (iOS or Android) compatible with the "syd" app.
  • Willing to provide informed consent and comply with study procedures

Who cannot join

  • Known severe psychiatric or cognitive conditions that impede app usage
  • Inability to provide informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pedro M Henriques, PhD contact

+351928091841

pedro.henriques@syd.life

Lorena Puica contact

lorena@syd.life

Saudi Arabia1 site
  • Alfaisal University

    Riyadh, 11533

    Ahmed Abu-Zaid, MD, +966568104818, amabuzaid@alfaisal.edu

    Ahmed Abu-Zaid, MD

Other trials in Saudi Arabia

About this study

Official title: A Randomized Controlled Trial to Assess the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia

The goal of this clinical trial is to learn if using the "See Yourself Differently" (syd) app can help improve quality of life and mental health for university students in Saudi Arabia. The study also aims to see if the app can help lower anxiety and stress, and increase positive feelings while decreasing negative feelings.

The main questions it aims to answer are:

Read more
  1. Does the "syd" app improve the quality of life for university students?
  2. Does the "syd" app help lower anxiety and stress in university students
  3. Does the "syd" app help increase positive feelings and decrease negative feelings in university students?

Researchers will compare students who use the "syd" app to see if it works.

Participants will:

  1. Use the "syd" app for 3 months.
  2. Complete surveys about their quality of life, anxiety, stress, and feelings.
Read the detailed description

This clinical trial outlines a prospective, parallel-group, single-blind randomised controlled trial to be conducted at Alfaisal University in the Kingdom of Saudi Arabia. The study will enrol 600 university students and staff members and will run for a 3-month intervention period.

The intervention focuses on the 'syd' mobile application, an AI-powered "Life Quality Mentor" designed to enhance users' quality of life. The app aims to support positive habit development by providing personalised feedback and continuous support. Key features include personalised guidance across various domains such as nutrition, sleep performance, stress management (including guided meditations and journaling), and financial well-being. The 'syd' app utilizes an advanced Artificial Intelligence (AI) platform, offering an AI conversational agent for motivational coaching, habit tracking tools, and integration with wearable technology.

Participants will be randomly allocated to either an experimental group, which will use the 'syd' app, or a control group. Those in the experimental group will be instructed to use the 'syd' app for the 3-month duration of the study.

Data will be collected at multiple time points: at baseline (prior to intervention), monthly during the 3-month intervention period, and at a final follow-up post-intervention. The primary data collection methods will involve validated research instruments (WHOQOL-BREF, PANAS-X, GAD-7, PSS) administered via Typeform surveys. Additionally, in-app data will be collected to monitor app usage, specifically the frequency and duration of engagement. Socio-demographic information will also be gathered.

Survey data will be stored securely within Typeform, and in-app data will be stored within the 'syd' application's database, hosted securely on Amazon Web Services (AWS). All data storage will comply with Alfaisal University's data security policies. To protect participant privacy, data will be anonymised or de-identified where possible, and access will be restricted to authorised research team members. Data will be encrypted during storage and transmission.

For data analysis, linear mixed-effects modelling will be employed, incorporating random intercepts for participants and fixed effects for time, group, and the time x group interaction. The analysis will adhere to intention-to-treat principles. Should missing data occur, multiple imputation will be considered if feasible. Data from Typeform surveys will be exported and cleaned, in-app data will be extracted and processed, and data from these different sources will be merged for comprehensive analysis

Being tested
See Yourself Differently (syd) mobile app
Keywords
syd, QoL, See Yourself Differently, Quality of Life, mHealth, App, RCT
Medical subject headings
Anxiety Disorders, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • See Yourself Differently (syd) mobile appDevice

    Also called syd, See Yourself Differently

    The 'syd' mobile app is designed as an AI-powered "Life Quality Mentor" with the primary aim of enhancing users' quality of life. The app focuses on positive habit development, personalised feedback, and continuous support. It offers personalised guidance across various domains, including Physical health, Emotional health, Brain power, Self-awareness, Purpose, Career, Financial health, Social life and Environment. It utilizes an advanced AI platform and offers features like personalised recommendations, supportive interaction with an AI mentor, habit tracking tools, and integration with wearable technology.

Study groups in NCT06979778
Study groupRoleWhat they receive
syd appExperimentalThe 'syd' application is designed as an AI-powered "Life Quality Mentor" with the primary aim of enhancing users' quality of life. The app focuses on positive habit development, personalised feedback, and continuous support. It offers personalised guidance across various domains, including Physical health, Emotional health, Brain power, Self-awareness, Purpose, Career, Financial health, Social life and Environment. It utilizes an advanced AI platform and offers features like personalised recommendations, supportive interaction with an AI mentor, habit tracking tools, and integration with wearable technology. The intervention arm will have full access to the 'syd' app and be able to interact with it for the 3 months duration of the trial
Receives: Device: See Yourself Differently (syd) mobile app
Wait list controlNo interventionThe wait list control arm will not receive access to the 'syd' app for the 3 months' duration of the trial, but will be given full lifetime access thereafter.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Quality of Life Domain Scores

    Quality of Life (QoL) as measured through the WHOQOL-BREF instrument. The WHOQOL-BREF is a 26-item questionnaire which uses a scoring system that assesses quality of life across four domains: physical health, psychological health, social relationships, and environmental health. Each item is scored on a 5-point scale (1-5) and transformed to a 0-100 scale. Domain scores are calculated by summing relevant item scores and transforming them to a 0-100 scale. Higher scores indicate better quality of life in a specific domain.

    Measured: From enrolment to the end of treatment at 3 months

Secondary outcomes (3)
  1. Change in Anxiety Score

    Change in Anxiety scores as measured through the General Anxiety Disorder-7 (GAD-7) questionnaire. The GAD-7 scoring system uses a simple system to assess anxiety levels. Each of the seven questions on the GAD-7 questionnaire is scored from 0 to 3, with 0 representing "not at all" and 3 representing "nearly every day." The total score is calculated by adding up the scores for all seven questions, resulting in a total score ranging from 0 to 21. Score interpretation: 0-4: Minimal to no anxiety; 5-9: Mild anxiety; 10-14: Moderate anxiety; 15 or higher: Severe anxiety.

    Measured: From enrolment to the end of treatment at 3 months

  2. Change in Perceived Stress Score

    Change in Perceived Stress Score as measured through the Perceived Stress Scale (PSS) questionnaire. The PSS scores are determined by summing individual item responses and interpreting the total score. Higher scores indicate a higher level of perceived stress. The total score can range from 0 to 56, with higher scores reflecting higher levels of stress.

    Measured: From enrolment to the end of treatment at 3 months

  3. Change in Positive and Negative Affect Scores

    Change in Positive and Negative Affect Scores as measured through the Positive and Negative Affect Schedule - Expanded Version (PANAS-X) questionnaire. The PANAS-X is composed of 60 items (emotions) on a 5-point scale (1 to 5) where participants can indicating how much they feel each emotion. A total positive and negative affect score is calculated by summing the responses for the respective sets of items. Higher scores on the positive affect scale indicate greater positive affect, while lower scores on the negative affect scale indicate less negative affect.

    Measured: From enrolment to the end of treatment at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study startMay 2025 (estimated)
  3. Primary completionAug 2025 (estimated)
  4. Study completionAug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06979778
Sponsor's protocol ID
20250512
Status last verified
May 2025
First submitted
12 May 2025
Last updated
23 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing See Yourself Differently (syd) mobile app in people with Quality of Life (QOL) and Anxiety, run by iamYiam Limited at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pedro M Henriques, PhD (+351928091841, pedro.henriques@syd.life), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Quality of Life Domain Scores (time frame: From enrolment to the end of treatment at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in